Inventor · disambiguated record
Michel Cogné
Also filed as: COGNE MICHEL · COGNÉ MICHEL
3 granted patents·5 pending applications·28 citations·filing 2004–2022
60Inventor score
Top patents by PatentIndex Score
8 records- 0178US8629317B2Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereofCOGNE MICHEL·Filed 2004·Granted Jan 14, 2014·28 cites·22 claims
- 0258US2025002596A1Neutralizing anti-cd95l monoclonal antibodiesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0352US2025281502A1New drug applicationCENTRE NAT RECH SCIENT·Filed 2022·Application pending·0 cites
- 0441US10398722B2Use of antisense oligonucleotides for producing truncated Ig by exon skipping for the treatment of diseases involving B cellsUNIV LIMOGES·Filed 2016·Granted Sep 3, 2019·0 cites·8 claims
- 0540US2021139599A1Recombinant immunoglobulins of a new igg5 class, encoded by the human heavy chain pseudo-gamma geneUNIV LIMOGES·Filed 2019·Application pending·0 cites
- 0640US2021024632A1Recombinant single chain immunoglobulinsFRANCAIS DU SANG ETS·Filed 2019·Application pending·0 cites
- 0735US2022235360A1Methods for modulating immunoglobulin expressionINSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDECALE·Filed 2020·Application pending·0 cites
- 0831US9872483B2Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodiesB CELL DESIGN·Filed 2014·Granted Jan 23, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Michel Cogné files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →